55: GLP-1 Diabetes: Ozempic and Wegovy Facts

Type 2 Diabetes Talk

In this episode, we delve into the world of Ozempic and Wegovy—two medications that have taken the diabetes and weight loss communities by storm.
Are these drugs the miracle solutions they’re touted to be, or do they come with hidden risks? We explore the science behind these GLP-1 receptor agonists, exploring how they impact blood sugar control and contribute to significant weight loss.
But it’s not just about the numbers. We candidly discuss the potential side effects and long-term implications of using these medications. From concerns about thyroid tumors to the reality of weight regain after discontinuation, you’ll gain insights into what these drugs mean for your health journey, particularly in the long term.
CHAPTERS
3:13 What is GLP-1
4:49 What are Ozempic and Wegovy
10:51 Potential consequences and risk factors of GLP-1 agonist drugs
14:16 Long term efficacy of GLP-1 medications and more risk factors
20:23 Surmounting benefits of GLP-1 drugs
21:31 Risks versus benefits

For show notes and resources, please visit: https://Type2DiabetesTalk.com
To share your questions and suggestions, leave us a voice message or email at: https://Type2DiabetesTalk.com/message
Explore our proven programs and services, visit: https://Type2DiabetesTalk.com/programs
Subscribe to our free weekly newsletter for podcast updates, valuable nutrition tips and more: https://Type2DiabetesTalk.com/subscribe

Capitole

1. 55: GLP-1 Diabetes: Ozempic and Wegovy Facts (00:00:00)

2. What is GLP-1 (00:03:13)

3. What are Ozempic and Wegovy (00:04:49)

4. Potential consequences and risk factors of GLP-1 agonist drugs (00:10:51)

5. Long term efficacy of GLP-1 medications and additional risk factors (00:14:16)

6. Surmounting benefits of GLP-1 drugs (00:20:23)

7. Risks versus benefits (00:21:31)